Navigation Links
Otonomy Enrolls First Patient in Pivotal Phase 2b Study of OTO-104 in Meniere's Disease
Date:12/11/2013

hair of the department of otolaryngology – head and neck surgery at Medical University of South Carolina, and clinical investigator for the Phase 2b clinical trial, "Unpredictable spontaneous vertigo is life altering and a source of considerable distress for patients with Meniere's disease, and there are currently no FDA-approved drug therapies. This study may bring us closer to providing a safe and effective treatment option for the many patients with this debilitating disorder."

The study will also assess the safety and tolerability of OTO-104, which is a proprietary, sustained-exposure otic formulation of dexamethasone. Upon screening, all subjects will enter into a 4-week observational period for a baseline assessment during which subjects will record their vertigo and tinnitus symptoms via a daily diary. Following the lead-in period, eligible subjects will be randomized 1:1 to a single intratympanic injection of 12 mg OTO-104 or placebo (gel vehicle). Tinnitus will also be assessed as a secondary endpoint in the study.

Additional information about study protocol and enrollment sites for the study can be found at www.clinicaltrials.gov using the study identifier NCT01412177.

About OTO-104
OTO-104 is a sustained-exposure formulation of the steroid dexamethasone that has been designed for intratympanic (IT) injection into the middle ear for the potential treatment of a broad range of inner ear disorders including vertigo and acute onset hearing loss. OTO-104 is based on Otonomy's proprietary formulation technology which is intended to overcome the limitations associated with the use of unapproved short-acting solutions in the ear. These include limited and variable drug exposure, need for repeat IT injections, and potential for suboptimal efficacy. OTO-104 successfully completed a Phase 1b trial in Meniere's disease patients that demonstrated a clinically meaningful reduction in vertigo f
'/>"/>

SOURCE Otonomy, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Otonomy Completes $45.9 Million Series C Equity Financing
2. Otonomy Acquires Assets and Patent Rights for Tinnitus Program
3. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
4. Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
5. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
6. ROX Medical enrolls first patients in Ireland for CONTROL-HTN hypertension trial at Beaumont and Mater Private Hospitals
7. ROX Medical enrolls first UK patients in CONTROL-HTN hypertension trial at Eastbourne General Hospital
8. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
9. Barts Hospital, London enrolls first patients in ROX Medicals CONTROL-HTN resistant hypertension trial
10. Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014  Major advances in radiation therapy and ... highlighted in a three-day Oncology Summit taking place ... 2014.  Renowned national and international cancer experts from seven ... exchange knowledge on modern technologies making treatment for ... The Summit will address a wide ...
(Date:7/10/2014)... SAN DIEGO , July 10, 2014  RESMED INC. ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
(Date:7/10/2014)...  Decision Resources Group finds that while more ... are willing to prescribe Durata,s Dalvance (dalbavancin) and ... OPAT, approximately two-thirds of the respondents reported a ... inpatients. However, our findings indicate that nearly two-thirds ... OPAT following hospital discharge, and most are discharged ...
Breaking Medicine Technology:Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 2 Questcor Pharmaceuticals, Inc . (Nasdaq: QCOR ) announced ... on Thursday, June 10, 2010 at The Grand Hyatt Hotel in ... Chief Executive Officer, will discuss the Company,s business strategy and historical financial performance ... , , ...
... CUPERTINO, Calif. , June 1 DURECT Corporation (Nasdaq: DRRX ) ... be presenting at the Jefferies Global Life Sciences Conference on Thursday, June 10 ... the Grand Hyatt Hotel in New York .   , ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) , , ...
Cached Medicine Technology:Questcor to Present at the Jefferies 2010 Global Life Sciences Conference 2DURECT to Present at the Jefferies Global Life Sciences Conference 2
(Date:7/12/2014)... 12, 2014 Sean Francis, owner of the Kawartha ... challenges to his clients. He’s also known for his support of ... a way to combine the two and is excited to announce ... the Boys and Girls Club. , The funds are the result ... June 23rd. Francis sent out emails and asked his clients to ...
(Date:7/12/2014)... For those who are unfamiliar with enzymes, they are ... in food. The enzymes literally break up the vitamins and ... absorbed by human bodies. According Dr. Henry Balzani, Medical Consultant ... food is the cause of many gastrointestinal health issues. ... DelPresto, a mother of 3 who is passionate about fitness ...
(Date:7/12/2014)... Lake City, Utah (PRWEB) July 12, 2014 ... spotlighted two types of startups, with awards being bestowed ... new emphasis spotlighted Utah’s outstanding entrepreneur community with recognition ... proving a sustainable model with incoming revenue. , 25 ... from across the state that are under 5 years ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Restore My ... Sen and Samantha Pearson, a couple boasting very impressive ... launch Restore My Vision Today as a way to ... ophthalmologists have become in their respective patients’ treatments ... privy to a “secret” trove of pertinent information relevant ...
(Date:7/11/2014)... Recently, MagicQuinceaneraDresses.com, the popular online supplier ... of 2014 Quinceanera dresses . The company’s new ... look fashionable without paying a large amount of money. ... 57% off. , The company’s online shop has become ... special occasion outfits. In addition to exquisite Quinceanera dresses, ...
Breaking Medicine News(10 mins):Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 3Health News:New Super Digestive Enzyme, DZ10, Supercharges The Digestion Process 2Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 2Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 3Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2
... 1 When Madonna sets out to adopt a child, ... people are being introduced to Malawi -- a small impoverished ... orphaned children range from 500,000 to over a million, help ... are raised in nurturing homes, with a mother and siblings, ...
... Honors Award(TM)RIDGEFIELD, Conn., April 1 Boehringer ... Association of Diversity Councils with the organization,s ... award recognizes the outstanding contributions of the ... lead diversity processes in their organizations and ...
... Pro:Idiom , Enable MSOs to Conveniently Deliver HD ... R.L. Drake , an American cable TV equipment ... solutions for over 65 years, has checked in as ... cable operators in the United States and Canada. ...
... exchange technology gives patients initial breast cancer screening ... unit FARMERVILLE, La., April 1 A breakthrough ... first time to over-40 women who live in ... http://www.newscom.com/cgi-bin/prnh/20090401/NY92660 ) ...
... with vascular birthmarks around the eye, even partial blockage ... amblyopia. Now a simple test can detect early ... vision testing, reports a study in the April issue ... http://www.elsevier.com/locate/ajo ) published by Elsevier. , Led by Dr. ...
... it Takes to Form a New Habit; Lack of Motivation ... Conn., April 1 According to ... brand bottled water, the number one bottled water brand in ... months or longer to form a new habit. However, experts ...
Cached Medicine News:Health News:In Malawi, Adoption is Not Enough 2Health News:Boehringer Ingelheim Recognized For Diversity And Inclusion Efforts 2Health News:Drake Nabs 'Suite Deal' as Distributor of Pro:Idiom(R) Hospitality Solution to U.S. and Canadian Cable Operators 2Health News:New Mobile Mammography Unit Offers Residents of Rural Northern Louisiana First-Ever Access to Free Breast Cancer Screening Exams 2Health News:New Mobile Mammography Unit Offers Residents of Rural Northern Louisiana First-Ever Access to Free Breast Cancer Screening Exams 3Health News:New Mobile Mammography Unit Offers Residents of Rural Northern Louisiana First-Ever Access to Free Breast Cancer Screening Exams 4Health News:Test allows early detection of vision problems in infants with hemangiomas of eyelids 2Health News:Video: New Survey Reveals Misconceptions About Forming New Habits 2Health News:Video: New Survey Reveals Misconceptions About Forming New Habits 3Health News:Video: New Survey Reveals Misconceptions About Forming New Habits 4
Double Ended Occluders...
Double Ended Occluders...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Short handle occluders are about 6 inches long....
Medicine Products: